Jennison Associates’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
|
|||||
2022
Q2 | $707K | Sell |
|
|||||
2022
Q1 | $33.8M | Sell |
|
|||||
2021
Q4 | $62.2M | Sell |
|
|||||
2021
Q3 | $54.2M | Sell |
|
|||||
2021
Q2 | $55.5M | Buy |
|
|||||
2021
Q1 | $56.6M | Buy |
|
|||||
2020
Q4 | $109M | Sell |
|
|||||
2020
Q3 | $75.7M | Buy |
|
|||||
2020
Q2 | $76.7M | Sell |
|
|||||
2020
Q1 | $47.2M | Sell |
|
|||||
2019
Q4 | $70.2M | Buy |
|
|||||
2019
Q3 | $57.8M | Sell |
|
|||||
2019
Q2 | $98.1M | Sell |
|
|||||
2019
Q1 | $117M | Sell |
|
|||||
2018
Q4 | $94.1M | Sell |
|
|||||
2018
Q3 | $122M | Sell |
|
|||||
2018
Q2 | $158M | Sell |
|
|||||
2018
Q1 | $155M | Buy |
|
|||||
2017
Q4 | $140M | Sell |
|
|||||
2017
Q3 | $147M | Buy |
|
|||||
2017
Q2 | $90M | Sell |
|
|||||
2017
Q1 | $64.4M | Sell |
|
|||||
2016
Q4 | $46.1M | Buy |
|
|||||
2016
Q3 | $58.5M | Buy |
|
|||||
2016
Q2 | $28.1M | Buy |
|
|||||
2016
Q1 | $43.4M | Buy |
|
|||||
2015
Q4 | $40M | Buy |
|
|||||
2015
Q3 | $55.8M | Buy |
|
|||||
2015
Q2 | $47.7M | Buy |
|